SPHK1 and pulmonary fibrosis: Given the importance of sphingosine kinase 1 (SPHK1) in promoting pulmonary fibrosis, we recently reported the first asbestos post-exposure study demonstrating that PF543, a specific SPHK1 inhibitor, can attenuate lung fibrosis when initiated 1 month following asbestos exposure [42].